Company Description
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.
The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners.
The company was incorporated in 2011 and is headquartered in South San Francisco, California.
| Country | United States |
| Founded | 2011 |
| IPO Date | Jun 6, 2025 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 916 |
| CEO | Sean Duffy |
Contact Details
Address: 611 Gateway Blvd, Suite 120 South San Francisco, California 94080 United States | |
| Phone | 888 987 8337 |
| Website | omadahealth.com |
Stock Details
| Ticker Symbol | OMDA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $19.00 |
| CIK Code | 0001611115 |
| CUSIP Number | 68170A108 |
| ISIN Number | US68170A1088 |
| Employer ID | 45-2355015 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Sean P. Duffy | Co-Founder, Chief Executive Officer and Director |
| Wei-Li Shao | President |
| Steven L. Cook | Chief Financial Officer |
| Lauren Fix | Senior Vice President of Corporate Strategy and Operations |
| Craig Gracey | Chief Accounting Officer |
| Sunil Kayiti | Chief Technology Officer |
| Allan Kells | Vice President of Investor Relations |
| Nathan Salha | General Counsel |
| Tom Scales | Senior Vice President of Sales and Payer Access |
| Nancy Vitale | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 28, 2026 | ARS | Filing |
| Apr 28, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 28, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 8, 2026 | 144 | Filing |
| Mar 13, 2026 | 144 | Filing |
| Mar 9, 2026 | 144 | Filing |
| Mar 6, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 6, 2026 | 10-K | Annual Report |
| Mar 5, 2026 | 8-K | Current Report |
| Mar 2, 2026 | SCHEDULE 13G | Filing |